| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Chemopotentiation of Fresh Acute Myelogenous Leukemic Cells by Recombinant Human Granulocyte - Macrophage Colony - Stimulating Factor ( GM-CSF ) and Methotrexate
Heung Tae Kim, Jin Seok Ahn, Eun Shil Kim, Yung Jue Bang, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc. 1998;30(2):357-369.
      
A Case of Acute Myelogenous Leukemia during Pregnancy
Jae Gyoon Lee, Sung Hyun Yang, Heung Tae Kim
J Korean Cancer Assoc. 1997;29(3):516-521.
      
A Case of Cervical Adenocarcinoma with Pulmonary Metastasis Resembling Miliary Tuberculosis
So Hee Sohn, Nah Hae Meung, Heung Tae Kim
J Korean Cancer Assoc. 1997;29(1):176-181.
      
Phase II study of 5-fluorouracil and recombinant interferon-gamma in patients with advanced colorectal cancer
Heung Tae Kim, Chang In Suh, Si Young Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 1992;24(5):743-758.
      
COP-BLAM III(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma
Keong Hae Jung, Young Iee Park, Kee Heung Lee, Young Suk Park, Chang In Suh, Won Ki Kang, Heung Tae Kim, Cheol Won Suh, Dae Seog Heo, Yung Jue Bang, Seonyang Park, Noe Kyeong Kim
J Korean Cancer Assoc. 1992;24(4):586-595.
      
Combination chemotherapy for the treatment of multiple myeloma
Hyo Jin Kim, Chang In Seo, Keun Chil Park, Heung Tae Kim, Dae Seog Heo, Yung Hue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc. 1992;24(4):577-585.
      
Phase II trial of recombinant interferon-gamma(LBD-001) in patients with malignancies
Chang In Suh, Won Ki Kang, Heung Tae Kim, Jae Hoon Lee, Dae Seog Heo, Yung Jue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim, Young Suk Park, Keun Chil Park, Sung Rok Kim
J Korean Cancer Assoc. 1992;24(4):549-561.
      
Palliative chemotherapy of soft tissue sarcoma with adriamycin and dacarbazine(ADIC) and cyclophosphamide, vinblastine, adriamycin and dacarbazine(CYVADIC)
Young Suk Park, Won Ki Kang, Chang In Suh, Heung Tae Kim, Hyo Jin Kim, Keun Chil Park, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 1992;24(3):401-410.
      
Induction of antileukemic cytotoxicity from peripheral blood lymphocytes of patients with acute myeloid leukemia
Yoon Koo Kang, Dae Seog Heo, Heung Tae Kim, Won Ki Kang, Keun Chil Park, Si Young Kim, Kyung Sam Cho, Sung Rok Kim, Sang Jae Lee, Byoung Kook Kim, Jin Oh Lee, Tae Woong Kang
J Korean Cancer Assoc. 1992;24(2):195-217.
      
Treatment of intermediate-grade non-Hodgkin's lymphoma with CAMP-MOB combination chemotherapy
Chang In Suh, Heung Tae Kim, Dong Bok Shin, Jae Hoon Lee, Dae Seog Heo, Yung Jue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc. 1992;24(1):102-108.
      
Malignant lymphomas in Korea
Heung Tae Kim, Young Hyeuk Im, Chang In Suh, Young Suk Park, Won Ki Kang, Due Seog Heo, Yung Jue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc. 1992;24(1):92-101.
      
Bleomycin, etoposide, cisplatin(BEF) combination chemotherapy for experimental germ cell tumor
Won Ki Kang, Chang In Suh, Young Suk Park, Young Hyuk Im, Heung Tae Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 1991;23(2):343-349.
      
5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma
Ki Hyeong Lee, Won Ki Kang, Chang In Suh, Young Suk Park, Heung Tae Kim, Yoon Koo Kang, Hyo Jin Kim, Dae Seog Heo, Yung Jue Bang, Yong Bum Yoon, Noe Kyeong Kim, Yong Hyun Park
J Korean Cancer Assoc. 1991;23(2):315-322.
      
5-fluorouracil and cisplatin(FP) combination chemotherapy in advanced gastric cancer patients treated previously with chemotherapy
Heung Tae Kim, Kyung Hae Jung, Won Ki Kang, Young Suk Park, Chang In Suh, Young Hyunk Im, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 1991;23(2):279-290.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI